Pages that link to "Q42100299"
Jump to navigation
Jump to search
The following pages link to The dropout problem in antihypertensive treatment. A pilot study of social and emotional factors influencing a patient's ability to follow antihypertensive treatment (Q42100299):
Displaying 50 items.
- The management of high blood pressure in general practice (Q34047545) (← links)
- Nontraditional problems of antihypertensive management. (Q34107555) (← links)
- The 90-Second Intervention: a patient compliance mediated technique to improve and control hypertension (Q34406273) (← links)
- Determinants of drug treatment maintenance among hypertensive persons in inner city Detroit. (Q34505351) (← links)
- Hypertension control through the design of targeted delivery models (Q34523015) (← links)
- Guidelines for making health education work (Q34543069) (← links)
- Issues in Patient Adherence to Health Care Regimens (Q34914787) (← links)
- Community Control of Hypertension: International Activities (Q35099382) (← links)
- Patient compliance--an overview (Q35596688) (← links)
- Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics (Q35825588) (← links)
- Long-term follow-up of a hypertension screening program (Q35959836) (← links)
- Control of hypertension in family practice by the doctor-nurse team. (Q35984019) (← links)
- Hypertension screening in general practice. Report on behalf of the General Practitioner Hypertension Study Group (Q35985437) (← links)
- High blood pressure: public views and knowledge (Q36305842) (← links)
- Treatment adherence in hypertension: problems and research (Q36950522) (← links)
- Improving adherence with medication: a selective literature review based on the example of hypertension treatment. (Q37632055) (← links)
- Health promotion and the use of appropriateness review (Q37788849) (← links)
- Antihypertensive treatment, compliance, and quality of life: Review of a little-understood relation (Q38162368) (← links)
- First-generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta-analysis. (Q38956366) (← links)
- Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension (Q39195699) (← links)
- Determinants of dropout rate among hypertensive patients in an urban clinic (Q39206066) (← links)
- An appointment reminder system's effect on reducing the number of hypertension patients who drop out from care. (Q39312415) (← links)
- Compliance with medication regimens among chronically ill, inner city patients (Q39358354) (← links)
- A social-psychological perspective on successful community control of high blood pressure: A review (Q39809426) (← links)
- An open, multicentre study of acebutolol, given as a single daily dose, in the management of hypertension (Q39915638) (← links)
- Essential hypertension in children and youth: A pediatric perspective (Q39944535) (← links)
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: A new long-acting beta-adrenoceptor blocking drug (Q40081704) (← links)
- Behavioral treatment of hyperlipidemia: techniques, results, and future directions (Q40344044) (← links)
- The association of knowledge and perception of medications with compliance and health states among hypertension patients: A prospective study (Q40385834) (← links)
- Hypertension Counseling (Q40432549) (← links)
- Once a Day Treatment of Hypertension (Q40499878) (← links)
- Compliance to treatment (Q40794659) (← links)
- Current drug treatment and treatment patterns with antihypertensive drugs (Q41107143) (← links)
- Retention of Cocaine Abusers in Outpatient Psychotherapy (Q41134780) (← links)
- The implications of noncompliance with antihypertensive medication (Q41139739) (← links)
- Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension (Q41156537) (← links)
- Research and Demonstration Issues in Self-Care: Measuring the Decline of Medicocentrism (Q41294973) (← links)
- Measurement of short-term, intermediate, and long-term outcomes of treating hypertension (Q41386351) (← links)
- The hypertensive patient: 6. Long-term follow-up (Q41435370) (← links)
- The control of hypertension in the community: no easy solution (Q41474029) (← links)
- Practical approach to hypertension. 1. Diagnostic evaluation (Q41518294) (← links)
- Compliance with treatment regimens in chronic asymptomatic diseases (Q41526091) (← links)
- Reasons for medical follow-up dropout among patients with arterial hypertension: the patient's perspective (Q42922846) (← links)
- The hypertensive patient: 5. Compliance with therapy (Q43118565) (← links)
- Compliance with antihypertensive medication (Q43157881) (← links)
- Differences between dropouts and active participants in a pediatric clinic for substance abuse mothers (Q43496659) (← links)
- Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classes (Q43868207) (← links)
- Compliance in Young Hypertensive Patients (Q44251539) (← links)
- Effect of lipid screening on preventive care decisions of nonparticipants (Q44264428) (← links)
- The Early Detection and Treatment of Hypertension (Q44493226) (← links)